APA (7th ed.) Citation

ES, K., S, C., BH, C., S, P., YJ, L., SJ, S., . . . B, K. (2024). Comparison of endoscopic healing and durability between infliximab originator and CT-P13 in pediatric patients with inflammatory bowel disease. Frontiers in immunology, 15, 1284181. https://doi.org/10.3389/fimmu.2024.1284181

Chicago Style (17th ed.) Citation

ES, Kim, et al. "Comparison of Endoscopic Healing and Durability Between Infliximab Originator and CT-P13 in Pediatric Patients with Inflammatory Bowel Disease." Frontiers in Immunology 15 (2024): 1284181. https://doi.org/10.3389/fimmu.2024.1284181.

MLA (9th ed.) Citation

ES, Kim, et al. "Comparison of Endoscopic Healing and Durability Between Infliximab Originator and CT-P13 in Pediatric Patients with Inflammatory Bowel Disease." Frontiers in Immunology, vol. 15, 2024, p. 1284181, https://doi.org/10.3389/fimmu.2024.1284181.